Cardlytics (CDLX)
(Delayed Data from NSDQ)
$2.43 USD
-0.33 (-11.80%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.45 +0.02 (0.82%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CDLX 2.43 -0.33(-11.80%)
Will CDLX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CDLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDLX
Cardlytics (CDLX) Reports Q2 Loss, Misses Revenue Estimates
Blade Air Mobility, Inc. (BLDE) Reports Q2 Loss, Tops Revenue Estimates
CDLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cardlytics (CDLX) Shows Fast-paced Momentum But Is Still a Bargain Stock
Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates
Priority Technology (PRTH) Surpasses Q1 Earnings Estimates
Other News for CDLX
CDLX forms Wide Range Bar on September 19
Is CDLX gaining bullish strength? Crossed Above 50 Day Moving Average shows up after rallying 92.66%
CDLX Crosses Above Average Analyst Target
Fell Below 50 Day Moving Average appears for CDLX after 6.54% move
CDLX Crossed Above 50 Day Moving Average on September 16